Important

Following the security measures legally established to prevent infection with the COVID-19 virus, the DBGen Ocular Genomics team will work remotely via telematics and reduce considerably the work in the lab. Queries and information requests will be addressed via email info@dbgen.com .

The DBGen Team (Barcelona 16/03/2020)

DBGen is a company that is devoted to genetic testing of hereditary eye diseases in a way that combines quality, diagnostic efficiency and engagement between the patient, the ophthalmologist and the companies requiring its services.

At DBGen we offer a quality, reliable and affordable genetic diagnosis that secures the clinical diagnosis and can guide the patient toward the right emerging therapies for genetic eye diseases. The genetic diagnosis can be used to identify asymptomatic relatives who carry the genetic defect, and is an essential step to provide genetic counseling.

 

Achromatopsia

 

Albinism

 

Glaucoma

 

Macular dystrophy

 

Retinitis pigmentosa

 

Non-affected vision

excellence in research and service
decisive commitment to the patient’s quality of life
genetic diagnosis applied to precision medicine

Team and experience

The company was founded by a team of specialized researchers in genetics at the University of Barcelona, who have been conducting basic research on genetic diseases of the retina for over 25 years.

Our team, which also includes experts in communications and management, as well as qualified technicians, is devoted to basic research and has contributed, through numerous publications, to identifying new pathogenic genes and mutations, and to building DNA diagnostic chips. The increased social demand for accurate genetic diagnoses from patients, associations and ophthalmologists is what drove us to create this genetic diagnostic service as a spin-off of the University of Barcelona.

Meet our team

350 MILLION
people are living with rare diseases
75%
are children
Blindness in children
6 out of 10
cases are inherited
6.000 - 8.000
Rare
diseases

>500 causative
genes

Collaborators and clients

APNES
ASANOL
CNAG
Feder
Fundació Bosch i Gimpera
Hospital Sant Joan de Déu
Instituto Oftalmológico Barraquer
Quirónsalud
Retina Asturias
Universitat de Barcelona
Visión España

What our clients say

DBGen fully aware that a molecular diagnosis is vitally important to a patient with retinal dystrophies, and undertakes its work with complete professionalism and responsibility, and, of course, empathy. They are available to address all your questions and concerns. You cannot choose a better place than DBGen to treat these cases. President of APNES Argentina
Our relationship with DGGen is extremely satisfactory. As a reference Pediatrics Hospital in Spain, we regularly examine many patients affected with different inherited ophthalmological disorders who require genetic testing. Their exhaustive genetic reports are instrumental for patient management and genetic counselling of the families.  From this collaboration some of our diagnosed patients are currently being considered for recruitment in gene therapy trials. Dr. Jaume Català-Mora. Pediatric Ophthalmologist. Retinal Department. Hospital Sant Joan de Déu. Esplugues de Llobregat. Barcelona. Spain
DBGen is our reliable provider of genetic diagnoses since 2016. The team at DBGen is fully committed to apply their long-standing experience and expertise to study the diagnoses of inherited visual disorders.  They combine successfully the latest advances in the field with state-of-the-art massive sequencing to offer high yield genetic diagnosis, even in difficult cases. Top added value of this company is the merging of high professionalism with close interaction with physicians and patients. Appraisal of Dr. Jeroni Nadal and Dr. Juan José Rodríguez Ezcurra, Instituto Oftalmológico Barraquer. Barcelona, Spain

Awards

The work of DBGen Ocular Genomics has been recognised with the following honors and awards

Awards

Who our services are for

Hospital ophthalmology units
Ophthalmology centers and clinics
Companies specializing in gene therapy
Associations of patients with hereditary ocular disorders
Patients with genetic eye disabilities